[#item_full_content]
HAYWARD, Calif.–(BUSINESS WIRE)– #biotechnology–Aarvik Therapeutics, an innovative, ADC-focused biotechnology company dedicated to engineering precision medicines for cancer therapy, is pleased to announce an investment by Laurus Labs, India in Aarvik’s recently-concluded Series Seed 2 financing round. Since launching in 2021, Aarvik has developed its proprietary MUTTA™ (MUlti-epitope Targeting Tetravalent Antibody) plaform with a focus on developing next generation antibody drug conjugates (ADCs) that can e